Milestone Scientific Introduces Advanced Epidural Technology

Introduction of CompuFlo® Epidural System at Pain Doctors Medical

Milestone Scientific Inc. (NYSE: MLSS), based in Roseland, New Jersey, has recently taken significant steps to revolutionize pain management with the deployment of its CompuFlo® Epidural System at Pain Doctors Medical LLC. This collaboration demonstrates a dedicated effort towards enhancing patient care and procedural efficiency in the realm of interventional pain management.

What is the CompuFlo® Epidural System?

The CompuFlo® Epidural System utilizes Milestone Scientific's unique Dynamic Pressure Sensing Technology®. This cutting-edge system provides real-time verification of the epidural needle's placement, dramatically improving the safety of the procedure. By confirming the location of the needle with precision, it minimizes complications and instills confidence in both medical professionals and patients.

Benefits for Medical Providers

Dr. Ilana Etelzon, a board-certified specialist in interventional pain management, has highlighted the system’s capabilities, stating that it represents a noteworthy technological advancement in epidural administration. The real-time feedback allows for a level of accuracy that enhances both patient and doctor confidence during procedures, paving the way for improved outcomes in pain management.

Impact on Patients' Treatment

With a growing emphasis on patient safety, the ability to confirm correct needle placement is vital. The integration of the CompuFlo® Epidural System at Pain Doctors Medical LLC signifies a positive shift towards providing comprehensive pain management solutions that prioritize the well-being of patients.

Market Penetration and Growth Outlook

This introduction of Milestone’s technology comes on the heels of recent changes to Medicare pricing which aim to increase the accessibility of the CompuFlo® Epidural System. The recognition of this system as a critical tool in pain management is expected to accelerate its adoption across various rehab and interventional centers. As more professionals acknowledge its clinical advantages, its footprint in the market is likely to expand.

Company Vision and Future Prospects

Milestone Scientific remains dedicated to expanding its reach within the interventional pain management landscape. Neal Goldman, Chairman and Interim CEO, emphasized the importance of collaborations with facilities like Pain Doctors Medical LLC in extending the benefits of the CompuFlo® technology. With enhancements in reimbursement approaches, Milestone anticipates continued advancement and acceptance of its systems within the medical community.

About Milestone Scientific Inc.

Milestone Scientific Inc. (MLSS) is a pioneering company dedicated to the development of innovative injection technologies for various medical and dental applications. Their computer-controlled systems aim to make injections accurate and comfortable while improving the overall safety of medical procedures. With their proprietary Dynamic Pressure Sensing Technology®, Milestone is at the forefront of revolutionizing injection techniques and enhancing patient experiences in medical settings.

Frequently Asked Questions

What is the CompuFlo® Epidural System?

The CompuFlo® Epidural System is a medical device that uses real-time pressure sensing technology to verify the accurate placement of epidural needles.

Who is utilizing this technology?

Pain Doctors Medical LLC, a specialized center for interventional pain management, is one of the first facilities to implement this system.

How does this benefit patients?

This technology enhances procedural accuracy, which in turn increases patient safety and reduces the risk of complications during epidural injections.

What is Milestone Scientific's mission?

Milestone Scientific aims to improve injection techniques and increase overall patient comfort and safety through innovative technologies.

How is the CompuFlo® Epidural System changing pain management?

By providing real-time feedback and greater precision, this system is setting a new standard for epidural procedures, leading to better patient outcomes.

About The Author

Olivia Taylor here, a 26-year-old writer and financial advisor. After earning a degree in finance, I worked in the sector for years. I've always loved numbers and had a talent for simplifying difficult financial ideas so that anyone could understand. I wrote my first book because of this passion; it helps readers take charge of their financial futures by fusing real-life stories with useful financial advice.

Whether they are just beginning their careers, preparing for significant life events, or seeking to invest wisely, my goal with my writing is to enable people to make educated financial decisions. The foundation of my work is the conviction that security and freedom of the individual are largely determined by financial literacy. To further financial education, I run workshops and frequently write for financial blogs in addition to my books.

I like to travel, experience other cultures, and find inspiration in daily life when I'm not writing or examining market trends. My passion is utilizing sound financial practices to help people reach their financial objectives and lead the best lives possible.

Contact Olivia Taylor privately here. Or send an email with ATTN: Olivia Taylor as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.